CoChat

Increased suicide attempt rate among patients interrupting use of atypical antipsychotics

Open access
Herings, Ron M. C., Erkens, Joëlle A. · 2003 · Pharmacoepidemiology and Drug Safety
Cited by 119

The DOI matches its Crossref record.

Abstract

Purpose: The aim of the study is to investigate whether patients at risk to commit suicide could be identified based on their drug refill patterns. Methods: Data for this study were obtained from the PHARMO system comprising drug‐dispensing data linked to hospital discharge records. All patients aged 15–45 years, suspected to suffer from schizophrenia and exclusive users of olanzapine or risperidone were selected. The use of antipsychotics was converted into treatment episodes of uninterrupted use. Therapy non‐compliance was defined as a drug holiday of at least 30 days. The follow‐up started with a treatment episode of at least 90 days. Relative risks for suicide attempts and 95% confidence limits due to drug holidays were estimated using Poisson regression analyses. Results: Of 603 patients, 33% interrupted treatment for at least 30 days. An increased suicide attempt rate was observed when comparing uninterrupted and interrupted drug use (20.0/1000 person years vs 72.1/1000 person years, respectively). A four‐fold increased risk for attempting suicide among patients with drug holidays was found (RR adjusted for age and gender 4.2, 95%CI: 1.7–10.1) compared to patients without drug holidays. Conclusions: Patients who do not refill atypical antipsychotics in time can be identified in the pharmacy and are most likely those with an increased risk to commit suicide. Copyright © 2003 John Wiley & Sons, Ltd.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/pds.837

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

Metadata

Authors
Herings, R. M. C., & Erkens, J. A.
Venue
Pharmacoepidemiology and Drug Safety
Publisher
Wiley
Published
2003-05-06
Volume
12
Issue
5
Pages
423-424
ISSN
  • 1053-8569 (ISSN-L)
  • 1099-1557
OpenAlex
W1997763686
Cited by
119
References
0
FWCI
7.11
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.